144896-51-5

Basic information

• Product Name: 4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE
• Synonyms: 4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE;4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE, 97 %;3,5-Dimethyl-4-benzyloxybenzaldehyde;4-Benzyloxy-3,5-dimethylbenzaldehyde, 98+%;3,5-dimethyl-4-phenylmethoxybenzaldehyde
• CAS NO: 144896-51-5
• Molecular Formula: C₁₆H₁₆O₂
• Molecular Weight: 240.3
• EINECS: -0
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Aldehydes;C10 to C21;Carbonyl Compounds;Building Blocks;C13-C60;Carbonyl Compounds;Chemical Synthesis;Organic Building Blocks
• Mol File: 144896-51-5.mol
• Article Data: 11

Chemical Properties

• Melting Point: 103-104 °C
• Boiling Point: 162-163°C 1mm
• Flash Point: >230 °F
• Appearance: /
• Density: 1.1 g/mL at 25 °C(lit.)
• Vapor Pressure: 4.23E-06mmHg at 25°C
• Refractive Index: n20/D 1.587(lit.)
• Sensitive: Air Sensitive
• CAS DataBase Reference: 4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE(144896-51-5)
• EPA Substance Registry System: 4-BENZYLOXY-3,5-DIMETHYLBENZALDEHYDE(144896-51-5)

Safety Data

• Statements: 36/37/38
• Safety Statements: 24/25
• WGK Germany: 3
• Hazardous Substances Data: 144896-51-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C16H16O2/c1-12-8-15(10-17)9-13(2)16(12)18-11-14-6-4-3-5-7-14/h3-10H,11H2,1-2H3

Upstream product

• 576-26-1 2.6-dimethylphenol 
• 2233-18-3 4-hydroxy-3,5-dimethylbenzaldehyde 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 

Downstream Products

• 1006685-34-2 (E)-1,3-bis(benzyloxy)-5-[4-(benzyloxy)-3,5-dimethylstyryl]-2-methylbenzene 
• 1006685-31-9 (E)-2-(benzyloxy)-5-[3,5-bis(benzyloxy)styryl]-1,3-dimethylbenzene 
• 1253731-89-3 2-(4-benzyloxy-3,5-dimethylphenyl)-7-fluoro-3H-quinazolin-4-one 
• 1253731-71-3 2-(4-benzyloxy-3,5-dimethylphenyl)-5,7-difluoro-3H-quinazolin-4-one 
• 1271727-97-9 C₂₇H₂₉NO₃ 
• 1268719-18-1 C₂₅H₂₃NO₃ 
• 1268719-19-2 C₁₈H₁₇NO₃ 

Relevant articles and documents

Synthesis of flavone derivatives via N-amination and evaluation of their anticancer activities

Seventeen new flavone derivatives substituted at the 40-OH position were designed, synthesized and evaluated for their anticancer and antibacterial activities. Among them, compounds 3, 4, 6f, 6e, 6b, 6c and 6k demonstrated the most potent antiproliferative activities against a human erythroleukemia cell line (HEL) and a prostate cancer cell line (PC3). The results also showed that the IC50 value of compounds 3, 4, 6f, 6e, 6b, 6c and 6k were close to that of the anticancer drug cisplatin (DDP) and lower than that of apigenin. All of the derivatives did not present antibacterial activities. The structure–activity relationships evaluation showed that the configuration of methyl amino acid might affect their biological activities.

Structure-Activity Relationships of cyclo(l -Tyrosyl- l -tyrosine) Derivatives Binding to Mycobacterium tuberculosis CYP121: Iodinated Analogues Promote Shift to High-Spin Adduct

A series of analogues of cyclo(l-tyrosyl-l-tyrosine), the substrate of the Mycobacterium tuberculosis enzyme CYP121, have been synthesized and analyzed by UV-vis and electron paramagnetic resonance spectroscopy and by X-ray crystallography. The introduction of iodine substituents onto cyclo(l-tyrosyl-l-tyrosine) results in sub-μM binding affinity for the CYP121 enzyme and a complete shift to the high-spin state of the heme FeIII. The introduction of halogens that are able to interact with heme groups is thus a feasible approach to the development of next-generation, tight binding inhibitors of the CYP121 enzyme, in the search for novel antitubercular compounds.

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.